Literature DB >> 562941

Cerebral dopamine agonist properties of some 2-aminotetralin derivatives after peripheral and intracerebral administration.

J G Cannon, T Lee, H D Goldman.   

Abstract

A series of variously N-substituted 2-aminotetralins having OH groups at 5 and 6 and at 6 and 7 positions, as well as nonoxygenated systems, has been evaluated for central dopaminergic effects. Stereotypical behavioral effects (sniffing, compulsive gnawing, and hyperactivity) produced by direct intracerebral administration of some of the agents were shown to differ strikingly from responses resulting from peripheral administration. The centrally mediated responses of hyperactivity and sterotypical gnawing-biting head and limb movements were shown to be separable in some test compounds. An improved route to 2-aminotetralin systems has been utilized for some of the compounds, which involves Pummerer rearrangement and cyclization of beta-keto sulfoxides and reductive amination of beta-tetralones with a NaBH4-carboxylic acid complex.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 562941     DOI: 10.1021/jm00219a001

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Structurally constrained hybrid derivatives containing octahydrobenzo[g or f]quinoline moieties for dopamine D2 and D3 receptors: binding characterization at D2/D3 receptors and elucidation of a pharmacophore model.

Authors:  Dennis A Brown; Prashant S Kharkar; Ingrid Parrington; Maarten E A Reith; Aloke K Dutta
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

Review 2.  Revision of the classical dopamine D2 agonist pharmacophore based on an integrated medicinal chemistry, homology modelling and computational docking approach.

Authors:  N Krogsgaard-Larsen; K Harpsøe; J Kehler; C T Christoffersen; P Brøsen; T Balle
Journal:  Neurochem Res       Date:  2014-07-24       Impact factor: 3.996

3.  In vitro acetylcholine release from rat caudate nucleus as a new model for testing drugs with dopamine-receptor activity.

Authors:  J C Stoof; R E Thieme; M C Vrijmoed-de Vries; A H Mulder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-11       Impact factor: 3.000

4.  Semi-rigid analogues of the calcium antagonist verapamil: a molecular modelling study.

Authors:  M N Romanelli; S Dei; S Scapecchi; E Teodori; F Gualtieri; R Budriesi; R Mannhold
Journal:  J Comput Aided Mol Des       Date:  1994-04       Impact factor: 3.686

5.  Neurochemical and behavioural profiles of five dopamine analogues.

Authors:  C Sumners; D Dijkstra; J B de Vries; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-07       Impact factor: 3.000

6.  [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalen (ADTN). Regional distribution and in vivo binding after acute and chronic drug treatment.

Authors:  Y Clement-Cormier; C E Smith
Journal:  Neurochem Res       Date:  1980-06       Impact factor: 3.996

7.  A comparison of the potencies of various dopamine receptor agonists in models for pre- and postsynaptic receptor activity.

Authors:  M G Feenstra; C Sumners; J H Goedemoed; J B de Vries; H Rollema; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

8.  Release of radiolabeled dopamine, p-tyramine, and m-tyramine from rat striatal slices by some aminotetralins.

Authors:  L E Dyck
Journal:  Neurochem Res       Date:  1981-04       Impact factor: 3.996

9.  Pharmacological evidence for the subclassification of central dopamine receptors in the rat.

Authors:  A J Gower; A S Marriott
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

10.  Apomorphine-induced limb flicks in cats: the role of dopamine receptors located outside the blood-brain barrier.

Authors:  B R Stewart; C L Broekkamp
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.